No specific human protein target

The designation "No specific human protein target" refers to a category of therapeutic agents that achieve their clinical effects through physical or chemical mechanisms rather than by binding to a specific human protein such as a receptor, enzyme, or transporter. This classification includes a diverse array of compounds, such as antacids (e.g., aluminum hydroxide) that work by directly neutralizing gastric hydrochloric acid to treat dyspepsia (StatPearls, 2023 [1]). Osmotic agents like mannitol function by creating an osmotic gradient in the renal tubules to promote water excretion, which is used to reduce intracranial or intraocular pressure (StatPearls, 2023 [2]). Other examples include activated charcoal, which physically adsorbs toxins within the gastrointestinal tract to prevent their systemic absorption (StatPearls, 2023 [3]), and ion-exchange resins like sodium polystyrene sulfonate that bind potassium in the gut. Because these agents do not rely on high-affinity protein-ligand interactions, their efficacy is primarily determined by their chemical concentration and physical properties within specific physiological compartments. This term is frequently utilized in pharmacological databases like ChEMBL and DrugBank to categorize drugs with non-canonical or non-biological targets (ChEMBL, 2024 [4]).

Other names

Non-protein targetNon-specific mechanismPhysicochemical mechanismNon-proteinaceous target

Chemical neutralization, osmotic gradient creation, physical adsorption, or chemical sequestration (chelation) of non-protein molecules.